Cargando…
The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin signalling pathway
OBJECTIVES: Hepatocellular carcinoma (HCC) is the second leading cause of cancer mortality worldwide. Alterations in microtubule-associated proteins (MAPs) have been observed in HCC. However, the mechanisms underlying these alterations remain poorly understood. Our aim was to study the roles of the...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036256/ https://www.ncbi.nlm.nih.gov/pubmed/26941395 http://dx.doi.org/10.1136/gutjnl-2015-310625 |
_version_ | 1782455528903933952 |
---|---|
author | Chen, Jianxiang Rajasekaran, Muthukumar Xia, Hongping Zhang, Xiaoqian Kong, Shik Nie Sekar, Karthik Seshachalam, Veerabrahma Pratap Deivasigamani, Amudha Goh, Brian Kim Poh Ooi, London Lucien Hong, Wanjin Hui, Kam M |
author_facet | Chen, Jianxiang Rajasekaran, Muthukumar Xia, Hongping Zhang, Xiaoqian Kong, Shik Nie Sekar, Karthik Seshachalam, Veerabrahma Pratap Deivasigamani, Amudha Goh, Brian Kim Poh Ooi, London Lucien Hong, Wanjin Hui, Kam M |
author_sort | Chen, Jianxiang |
collection | PubMed |
description | OBJECTIVES: Hepatocellular carcinoma (HCC) is the second leading cause of cancer mortality worldwide. Alterations in microtubule-associated proteins (MAPs) have been observed in HCC. However, the mechanisms underlying these alterations remain poorly understood. Our aim was to study the roles of the MAP protein regulator of cytokinesis 1 (PRC1) in hepatocarcinogenesis and early HCC recurrence. DESIGN: PRC1 expression in HCC samples was evaluated by microarray, immunoblotting and immunohistochemistry analysis. Molecular and cellular techniques including siRNA-mediated and lentiviral vector-mediated knockdown were used to elucidate the functions and mechanisms of PRC1. RESULTS: PRC1 expression was associated with early HCC recurrence and poor patient outcome. In HCC, PRC1 exerted an oncogenic effect by promoting cancer proliferation, stemness, metastasis and tumourigenesis. We further demonstrated that the expression and distribution of PRC1 is dynamically regulated by Wnt3a signalling. PRC1 knockdown impaired transcription factor (TCF) transcriptional activity, decreased Wnt target expression and reduced nuclear β-catenin levels. Mechanistically, PRC1 interacts with the β-catenin destruction complex, regulates Wnt3a-induced membrane sequestration of this destruction complex, inhibits adenomatous polyposis coli (APC) stability and promotes β-catenin release from the APC complex. In vivo, high PRC1 expression correlated with nuclear β-catenin and Wnt target expression. PRC1 acted as a master regulator of a set of 48 previously identified Wnt-regulated recurrence-associated genes (WRRAGs) in HCC. Thus, PRC1 controlled the expression and function of WRRAGs such as FANCI, SPC25, KIF11 and KIF23 via Wnt signalling. CONCLUSIONS: We identified PRC1 as a novel Wnt target that functions in a positive feedback loop that reinforces Wnt signalling to promote early HCC recurrence. |
format | Online Article Text |
id | pubmed-5036256 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-50362562016-10-17 The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin signalling pathway Chen, Jianxiang Rajasekaran, Muthukumar Xia, Hongping Zhang, Xiaoqian Kong, Shik Nie Sekar, Karthik Seshachalam, Veerabrahma Pratap Deivasigamani, Amudha Goh, Brian Kim Poh Ooi, London Lucien Hong, Wanjin Hui, Kam M Gut Hepatology OBJECTIVES: Hepatocellular carcinoma (HCC) is the second leading cause of cancer mortality worldwide. Alterations in microtubule-associated proteins (MAPs) have been observed in HCC. However, the mechanisms underlying these alterations remain poorly understood. Our aim was to study the roles of the MAP protein regulator of cytokinesis 1 (PRC1) in hepatocarcinogenesis and early HCC recurrence. DESIGN: PRC1 expression in HCC samples was evaluated by microarray, immunoblotting and immunohistochemistry analysis. Molecular and cellular techniques including siRNA-mediated and lentiviral vector-mediated knockdown were used to elucidate the functions and mechanisms of PRC1. RESULTS: PRC1 expression was associated with early HCC recurrence and poor patient outcome. In HCC, PRC1 exerted an oncogenic effect by promoting cancer proliferation, stemness, metastasis and tumourigenesis. We further demonstrated that the expression and distribution of PRC1 is dynamically regulated by Wnt3a signalling. PRC1 knockdown impaired transcription factor (TCF) transcriptional activity, decreased Wnt target expression and reduced nuclear β-catenin levels. Mechanistically, PRC1 interacts with the β-catenin destruction complex, regulates Wnt3a-induced membrane sequestration of this destruction complex, inhibits adenomatous polyposis coli (APC) stability and promotes β-catenin release from the APC complex. In vivo, high PRC1 expression correlated with nuclear β-catenin and Wnt target expression. PRC1 acted as a master regulator of a set of 48 previously identified Wnt-regulated recurrence-associated genes (WRRAGs) in HCC. Thus, PRC1 controlled the expression and function of WRRAGs such as FANCI, SPC25, KIF11 and KIF23 via Wnt signalling. CONCLUSIONS: We identified PRC1 as a novel Wnt target that functions in a positive feedback loop that reinforces Wnt signalling to promote early HCC recurrence. BMJ Publishing Group 2016-09 2016-03-03 /pmc/articles/PMC5036256/ /pubmed/26941395 http://dx.doi.org/10.1136/gutjnl-2015-310625 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Hepatology Chen, Jianxiang Rajasekaran, Muthukumar Xia, Hongping Zhang, Xiaoqian Kong, Shik Nie Sekar, Karthik Seshachalam, Veerabrahma Pratap Deivasigamani, Amudha Goh, Brian Kim Poh Ooi, London Lucien Hong, Wanjin Hui, Kam M The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin signalling pathway |
title | The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin signalling pathway |
title_full | The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin signalling pathway |
title_fullStr | The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin signalling pathway |
title_full_unstemmed | The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin signalling pathway |
title_short | The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin signalling pathway |
title_sort | microtubule-associated protein prc1 promotes early recurrence of hepatocellular carcinoma in association with the wnt/β-catenin signalling pathway |
topic | Hepatology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036256/ https://www.ncbi.nlm.nih.gov/pubmed/26941395 http://dx.doi.org/10.1136/gutjnl-2015-310625 |
work_keys_str_mv | AT chenjianxiang themicrotubuleassociatedproteinprc1promotesearlyrecurrenceofhepatocellularcarcinomainassociationwiththewntbcateninsignallingpathway AT rajasekaranmuthukumar themicrotubuleassociatedproteinprc1promotesearlyrecurrenceofhepatocellularcarcinomainassociationwiththewntbcateninsignallingpathway AT xiahongping themicrotubuleassociatedproteinprc1promotesearlyrecurrenceofhepatocellularcarcinomainassociationwiththewntbcateninsignallingpathway AT zhangxiaoqian themicrotubuleassociatedproteinprc1promotesearlyrecurrenceofhepatocellularcarcinomainassociationwiththewntbcateninsignallingpathway AT kongshiknie themicrotubuleassociatedproteinprc1promotesearlyrecurrenceofhepatocellularcarcinomainassociationwiththewntbcateninsignallingpathway AT sekarkarthik themicrotubuleassociatedproteinprc1promotesearlyrecurrenceofhepatocellularcarcinomainassociationwiththewntbcateninsignallingpathway AT seshachalamveerabrahmapratap themicrotubuleassociatedproteinprc1promotesearlyrecurrenceofhepatocellularcarcinomainassociationwiththewntbcateninsignallingpathway AT deivasigamaniamudha themicrotubuleassociatedproteinprc1promotesearlyrecurrenceofhepatocellularcarcinomainassociationwiththewntbcateninsignallingpathway AT gohbriankimpoh themicrotubuleassociatedproteinprc1promotesearlyrecurrenceofhepatocellularcarcinomainassociationwiththewntbcateninsignallingpathway AT ooilondonlucien themicrotubuleassociatedproteinprc1promotesearlyrecurrenceofhepatocellularcarcinomainassociationwiththewntbcateninsignallingpathway AT hongwanjin themicrotubuleassociatedproteinprc1promotesearlyrecurrenceofhepatocellularcarcinomainassociationwiththewntbcateninsignallingpathway AT huikamm themicrotubuleassociatedproteinprc1promotesearlyrecurrenceofhepatocellularcarcinomainassociationwiththewntbcateninsignallingpathway AT chenjianxiang microtubuleassociatedproteinprc1promotesearlyrecurrenceofhepatocellularcarcinomainassociationwiththewntbcateninsignallingpathway AT rajasekaranmuthukumar microtubuleassociatedproteinprc1promotesearlyrecurrenceofhepatocellularcarcinomainassociationwiththewntbcateninsignallingpathway AT xiahongping microtubuleassociatedproteinprc1promotesearlyrecurrenceofhepatocellularcarcinomainassociationwiththewntbcateninsignallingpathway AT zhangxiaoqian microtubuleassociatedproteinprc1promotesearlyrecurrenceofhepatocellularcarcinomainassociationwiththewntbcateninsignallingpathway AT kongshiknie microtubuleassociatedproteinprc1promotesearlyrecurrenceofhepatocellularcarcinomainassociationwiththewntbcateninsignallingpathway AT sekarkarthik microtubuleassociatedproteinprc1promotesearlyrecurrenceofhepatocellularcarcinomainassociationwiththewntbcateninsignallingpathway AT seshachalamveerabrahmapratap microtubuleassociatedproteinprc1promotesearlyrecurrenceofhepatocellularcarcinomainassociationwiththewntbcateninsignallingpathway AT deivasigamaniamudha microtubuleassociatedproteinprc1promotesearlyrecurrenceofhepatocellularcarcinomainassociationwiththewntbcateninsignallingpathway AT gohbriankimpoh microtubuleassociatedproteinprc1promotesearlyrecurrenceofhepatocellularcarcinomainassociationwiththewntbcateninsignallingpathway AT ooilondonlucien microtubuleassociatedproteinprc1promotesearlyrecurrenceofhepatocellularcarcinomainassociationwiththewntbcateninsignallingpathway AT hongwanjin microtubuleassociatedproteinprc1promotesearlyrecurrenceofhepatocellularcarcinomainassociationwiththewntbcateninsignallingpathway AT huikamm microtubuleassociatedproteinprc1promotesearlyrecurrenceofhepatocellularcarcinomainassociationwiththewntbcateninsignallingpathway |